Related Experiment Video
Updated: May 5, 2026

08:30
Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
12.7K
Risk Factors for Anti-Glaucoma Surgery in Posner-Schlossman Syndrome Patients: an 8-Year Retrospective Study
Jiaxing Xie1,2,3, Ruofan Li1,2, Qianqian Ji1,2
1Department of Ophthalmology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing 100191, China.
International Journal of Medical Sciences
|May 4, 2026
Summary
Older age, frequent attacks, and RNFL defects increase the risk of anti-glaucoma surgery in Chinese patients with Posner-Schlossman Syndrome (PSS). This retrospective study highlights key factors for surgical intervention in PSS management.
Area of Science:
- Ophthalmology
- Glaucoma Research
- Surgical Risk Factors
Background:
- Posner-Schlossman Syndrome (PSS) is a recurrent uveitis condition.
- Identifying risk factors for anti-glaucoma surgery is crucial for managing PSS patients.
- Previous studies have not comprehensively evaluated surgical risk in this population.
Purpose of the Study:
- To investigate the risk factors associated with the need for anti-glaucoma surgery in Chinese patients diagnosed with Posner-Schlossman Syndrome.
- To identify specific clinical and demographic predictors that influence surgical outcomes in PSS.
Main Methods:
- A retrospective study was conducted involving 106 Chinese Posner-Schlossman Syndrome patients.
- Patients were categorized into low-frequency (<2 attacks/year) and high-frequency (≥2 attacks/year) groups.
- Data on general information, ocular manifestations, and medical treatments were collected and analyzed, with a focus on risk factors for anti-glaucoma surgery.
Main Results:
- The high-frequency attack group exhibited longer disease duration, more iris atrophy, and increased use of systemic ganciclovir.
- Patients with higher attack frequency had a greater tendency for secondary glaucoma and a higher probability of requiring anti-glaucoma surgery.
- Binary logistic regression identified older age of onset (OR=1.080), higher attack frequency (OR=6.186), and RNFL defect (OR=4.804) as significant risk factors for anti-glaucoma surgery.
Conclusions:
- Elderly age of onset, increased frequency of attacks, and the presence of RNFL defects are significant risk factors for undergoing anti-glaucoma surgery in Posner-Schlossman Syndrome patients.
- These findings aid in predicting surgical necessity and optimizing treatment strategies for PSS.
- Further research could explore preventative measures against these identified risk factors.
Related Concept Videos
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K

